Compare · AVNS vs STE
AVNS vs STE
Side-by-side comparison of Avanos Medical Inc. (AVNS) and STERIS plc (Ireland) (STE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AVNS and STE operate in Industrial Specialties (Health Care), so they compete in similar markets.
- STE is the larger of the two at $23.05B, about 19.7x AVNS ($1.17B).
- STE has been more active in the news (16 items in the past 4 weeks vs 1 for AVNS).
- STE has more recent analyst coverage (17 ratings vs 7 for AVNS).
- Company
- Avanos Medical Inc.
- STERIS plc (Ireland)
- Price
- -
- -
- Market cap
- $1.17B
- $23.05B
- 1M return
- +0.32%
- -
- 1Y return
- +116.36%
- -
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NYSE
- IPO
- 2014
- News (4w)
- 1
- 16
- Recent ratings
- 7
- 17
Avanos Medical Inc.
Avanos Medical, Inc. operates as a medical technology company that focuses on delivering medical device solutions to improve patients' quality of life in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands. The company also provides a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems; and interventional pain solutions, which offers minimally invasive pain relieving therapies, such as Coolief pain relief therapy. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.
STERIS plc (Ireland)
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. This segment offers its products and services to acute care hospitals and other healthcare settings. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The company is based in Dublin, Ireland.
Latest AVNS
- SEC Form 15-12G filed by Avanos Medical Inc.
- SEC Form S-8 POS filed by Avanos Medical Inc.
- Avanos Medical Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits
- SVP, Operations Delgado Sigfrido returned $2,765,675 worth of shares to the company (110,627 units at $25.00) and was granted 54,886 shares, closing all direct ownership in the company (SEC Form 4) (tax liability)
- SVP, Chief Financial Officer Galovan Scott Michael returned $5,792,925 worth of shares to the company (231,717 units at $25.00) and was granted 96,121 shares, closing all direct ownership in the company (SEC Form 4) to satisfy tax liability
- Chief Executive Officer Pacitti David returned $19,173,100 worth of shares to the company (766,924 units at $25.00) and was granted 444,730 shares, closing all direct ownership in the company (SEC Form 4) (tax liability)
- Director Shimer Julie Ann returned $1,252,250 worth of shares to the company (50,090 units at $25.00), closing all direct ownership in the company (SEC Form 4) to cover taxes
- Director Oleary Patrick J returned $1,366,000 worth of shares to the company (54,640 units at $25.00), closing all direct ownership in the company (SEC Form 4) (for tax liability)
- Director Franchini Indrani Lall returned $120,425 worth of shares to the company (4,817 units at $25.00), closing all direct ownership in the company (SEC Form 4) (for withholding tax)
- Director Egbuonu-Davis Lisa returned $345,275 worth of shares to the company (13,811 units at $25.00), closing all direct ownership in the company (SEC Form 4) (for tax liability)
Latest STE
- SEC Form 144 filed by STERIS plc (Ireland)
- SEC Form 4 filed by Director Shapiro Louis
- Director Sohi Mohsen exercised 4,058 units of Ordinary Shares at a strike of $86.23 and sold $956,795 worth of Ordinary Shares (4,058 units at $235.78) (SEC Form 4)
- SEC Form 4 filed by Director Shah Nirav R
- SEC Form 4 filed by Director Martin Paul Edward
- SEC Form 4 filed by Director Boulud Pierre
- SEC Form 4 filed by Director Feldmann Cynthia L
- SEC Form 4 filed by Director Holland Christopher S
- SEC Form 4 filed by Director Alegria Esther M.
- SEC Form 144 filed by STERIS plc (Ireland)